乳房再発スコア検査に関する市場調査：この分野で地域市場をリードする北米

Market Study on Breast Recurrence Score Tests: North America Leading Regional Market in This Space

乳房再発スコア検査市場：レポート範囲 Persistence Market Research社の最新レポート「世界の乳房再発スコア検査市場」は、市場機会と現在の市場展望を評価し、市場に影響を与える対応セクションに関する詳細... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Persistence Market Research パーシスタンスマーケットリサーチ	2023年7月24日	US$4,900 シングルユーザライセンスライセンス・価格情報注文方法はこちら	233	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

乳房再発スコア検査市場：レポート範囲

Persistence Market Research社の最新レポート「世界の乳房再発スコア検査市場」は、市場機会と現在の市場展望を評価し、市場に影響を与える対応セクションに関する詳細な分析と最新情報を提供しています。この調査レポートは、市場の促進要因、阻害要因、動向、機会を含む現在の市場ダイナミクスに関する詳細な洞察を提供しています。市場調査の主な目的は、2023年から2033年の予測期間中に市場がどのように推移するかについての独占情報を提示することです。

市場の成功成長のための重要な指標は、市場の前年比（YoY）成長分析、複合年間成長率（CAGR）を含むこの包括的なレポートで提示され、Persistence Market Research社の調査で網羅的に説明されています。この調査レポートは、乳房再発スコア検査製品の需要と調査期間中の定量的な発展機会を知る読者を支援することができます。

本調査は、投資家、メーカー、サービスプロバイダ、流通業者、サプライヤなどのランドスケープにおける株主にとって有益であり、乳房再発スコア検査市場で繁栄するための適切な事業戦略を策定する際に役立ちます。乳房再発スコア検査市場の株主、業界専門家、投資家、研究者、報道関係者、ビジネス愛好家は、このPersistence Market Researchの調査レポートで紹介されている洞察や情報を活用することができます。

市場統計、ならびに乳房再発スコア検査市場のビジネスシナリオに影響を与えるマクロ経済変数およびマクロ経済変数に関連する情報も、本調査に含まれています。市場の潜在的な発展に応じて、実質的な洞察もこのレポートで遭遇します。さらに、本レポートで提出されたデータにより、業界のマイナー企業や新規参入企業は、市場での牽引力を達成するために適切な企業選択を行う際に役立ちます。

主要市場セグメント

Persistence Market Research社の乳房再発スコア検査市場に関する調査レポートは、製品、適応症、エンドユーザー、地域の4つの重要なセグメントに分けた情報を提供しています。本レポートは、これらのカテゴリに関連する重要な市場ダイナミクスと成長パラメータに関する包括的なデータと情報を提供します。

属性詳細
製品
検査キット
試薬・消耗品
適応症
ステージ1乳がん
ステージ2乳がん
エストロゲン受容体陽性がん
リンパ節転移陰性がん
エンドユーザー
病院
専門がんセンター
診断センター
がん研究機関
地域
北米
ラテンアメリカ
ヨーロッパ
南アジア
東アジア
オセアニア
中東・アフリカ（MEA）
レポートで回答した主な質問

今後数年間、乳房再発スコア検査製品にとって最も収益性の高い市場であり続けるのはどの地域か？
トレンドの変化は市場にどのような影響を与えるか？
市場プレイヤーは先進地域の低空飛行チャンスをどのように捉えることができるか？
このような状況において、利害関係者はどのような戦略で自らのポジションを確立しているのか？
投資家が市場に投資する際に注意すべき、また取り組む可能性のある阻害要因は何か？
市場に影響を与える開発動向は何か？
乳房再発スコア検査市場の企業は、先進国および新興国の成長機会をどのように利用できるか？
調査方法

Persistence Market Research社の調査レポートでは、乳房再発スコア検査市場の成長に関する広範な調査を実施し、市場の今後の成長パラメータに関する結論を得るために、独自の調査手法を活用しています。この調査手法は一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立ちます。

市場調査作成中にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは、一次資料として本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行った。

一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、乳房再発スコア検査市場の成長見通しに関するPersistence Market Research社の予測をより正確で信頼性の高いものにしています。

ページTOPに戻る

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply-Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Value Added Insights

4.1. Product Adoption Analysis

4.2. Product USPs/Features

4.3. Regulatory Landscape, By Country

4.4. Recent Product Approval/Launches

4.5. Disease Epidemiology

4.6. PESTLE Analysis

4.7. Value Chain Analysis

4.8. Unmet Needs

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global Healthcare Expenditure Outlook

5.1.2. Global Life Science Market Outlook

5.1.3. Global Breast Cancer Diagnostics Market Outlook

5.2. Forecast Factors - Relevance & Impact

5.2.1. Rising Prevalence of Breast Cancer

5.2.2. Increase in Research and Development

5.2.3. Strategic Collaborations among players

5.2.4. Cost of Product

5.2.5. Adoption Rate

5.2.6. Frequency of Product Approval

5.2.7. Government Initiative

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. Global Market Demand Volume (Units) Analysis 2017–2022 and Forecast, 2023–2033

6.1. Historical Market Volume (Units) Analysis, 2017–2022

6.2. Current and Future Market Volume (Units) Projections, 2023–2033

6.2.1. Y-o-Y Growth Trend Analysis

7. Global Market – Pricing Analysis

7.1. Regional Pricing Analysis By Product

7.2. Global Average Pricing Analysis Benchmark

7.3. Pricing Assumptions

8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017–2022 and Forecast, 2023–2033

8.1. Historical Market Value (US$ Mn) Analysis, 2017–2022

8.2. Current and Future Market Size (US$ Mn) Projections, 2023–2033

8.2.1. Y-o-Y Growth Trend Analysis

8.2.2. Absolute $ Opportunity Analysis

8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic

9. Global Market Analysis 2017–2022 and Forecast 2023–2033, By Product

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2017–2022

9.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product, 2023–2033

9.3.1. Test Kits

9.3.2. Reagents & Consumables

9.4. Market Attractiveness Analysis By Product

10. Global Market Analysis 2017–2022 and Forecast 2023–2033, By Indication

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2017–2022

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2023–2033

10.3.1. Stage 1 Breast Cancer

10.3.2. Stage 2 Breast Cancer

10.3.3. Estrogen-receptor Positive Cancer

10.3.4. Lymph-node Negative Cancer

10.4. Market Attractiveness Analysis By Indication

11. Global Market Analysis 2017–2022 and Forecast 2023–2033, By End User

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2022

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033

11.3.1. Hospitals

11.3.2. Specialty Cancer Centers

11.3.3. Diagnostic Centers

11.3.4. Cancer Research Institutions

11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2017–2022 and Forecast 2023–2033, by Region

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2017–2022

12.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis Forecast By Region, 2023–2033

12.3.1. North America

12.3.2. Latin America

12.3.3. Europe

12.3.4. South Asia

12.3.5. East Asia

12.3.6. Oceania

12.3.7. Middle East and Africa

12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2017–2022 and Forecast 2023–2033

13.1. Introduction / Key Findings

13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022

13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033

13.3.1. By Country

13.3.1.1. U.S.

13.3.1.2. Canada

13.3.2. By Product

13.3.3. By Indication

13.3.4. By End User

13.4. Market Attractiveness Analysis By Region

13.4.1. By Country

13.4.2. By Product

13.4.3. By Indication

13.4.4. By End User

13.5. Market trends

13.6. Key Market Participants - Intensity Mapping

13.7. Drivers and Restraints - Impact Analysis

13.8. Country Level Analysis & Forecast

13.8.1. U.S. Market Analysis

13.8.1.1. Introduction

13.8.1.2. Market Analysis and Forecast by Market Taxonomy

13.8.1.2.1. By Product

13.8.1.2.2. By Indication

13.8.1.2.3. By End User

13.8.2. Canada Market Analysis

13.8.2.1. Introduction

13.8.2.2. Market Analysis and Forecast by Market Taxonomy

13.8.2.2.1. By Product

13.8.2.2.2. By Indication

13.8.2.2.3. By End User

14. Latin America Market Analysis 2017–2022 and Forecast 2023–2033

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022

14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033

14.3.1. By Country

14.3.1.1. Brazil

14.3.1.2. Mexico

14.3.1.3. Argentina

14.3.1.4. Rest of Latin America

14.3.2. By Product

14.3.3. By Indication

14.3.4. By End User

14.4. Market Attractiveness Analysis By Region

14.4.1. By Country

14.4.2. By Product

14.4.3. By Indication

14.4.4. By End User

14.5. Market trends

14.6. Key Market Participants - Intensity Mapping

14.7. Drivers and Restraints - Impact Analysis

14.8. Country Level Analysis & Forecast

14.8.1. Brazil Market Analysis

14.8.1.1. Introduction

14.8.1.2. Market Analysis and Forecast by Market Taxonomy

14.8.1.2.1. By Product

14.8.1.2.2. By Indication

14.8.1.2.3. By End User

14.8.2. Mexico Market Analysis

14.8.2.1. Introduction

14.8.2.2. Market Analysis and Forecast by Market Taxonomy

14.8.2.2.1. By Product

14.8.2.2.2. By Indication

14.8.2.2.3. By End User

14.8.3. Argentina Market Analysis

14.8.3.1. Introduction

14.8.3.2. Market Analysis and Forecast by Market Taxonomy

14.8.3.2.1. By Product

14.8.3.2.2. By Indication

14.8.3.2.3. Type By End User

15. Europe Market Analysis 2017–2022 and Forecast 2023–2033

15.1. Introduction / Key Findings

15.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2017–2022

15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033

15.3.1. By Country

15.3.1.1. Germany

15.3.1.2. France

15.3.1.3. Spain

15.3.1.4. Russia

15.3.1.5. Italy

15.3.1.6. BENELUX

15.3.1.7. U.K.

15.3.1.8. Rest of Europe

15.3.2. By Product

15.3.3. By Indication

15.3.4. By End User

15.4. Market Attractiveness Analysis By Region

15.4.1. By Country

15.4.2. By Product

15.4.3. By Indication

15.4.4. By End User

15.5. Market trends

15.6. Key Market Participants - Intensity Mapping

15.7. Drivers and Restraints - Impact Analysis

15.8. Country Level Analysis & Forecast

15.8.1. Germany Market Analysis

15.8.1.1. Introduction

15.8.1.2. Market Analysis and Forecast by Market Taxonomy

15.8.1.2.1. By Product

15.8.1.2.2. By Indication

15.8.1.2.3. By End User

15.8.2. France Market Analysis

15.8.2.1. Introduction

15.8.2.2. Market Analysis and Forecast by Market Taxonomy

15.8.2.2.1. By Product

15.8.2.2.2. By Indication

15.8.2.2.3. By End User

15.8.3. Spain Market Analysis

15.8.3.1. Introduction

15.8.3.2. Market Analysis and Forecast by Market Taxonomy

15.8.3.2.1. By Product

15.8.3.2.2. By Indication

15.8.3.2.3. Type By End User

15.8.4. Russia Market Analysis

15.8.4.1. Introduction

15.8.4.2. Market Analysis and Forecast by Market Taxonomy

15.8.4.2.1. By Product

15.8.4.2.2. By Indication

15.8.4.2.3. Type By End User

15.8.5. Italy Market Analysis

15.8.5.1. Introduction

15.8.5.2. Market Analysis and Forecast by Market Taxonomy

15.8.5.2.1. By Product

15.8.5.2.2. By Indication

15.8.5.2.3. By End User

15.8.6. BENELUX Market Analysis

15.8.6.1. Introduction

15.8.6.2. Market Analysis and Forecast by Market Taxonomy

15.8.6.2.1. By Product

15.8.6.2.2. By Indication

15.8.6.2.3. By End User

15.8.7. U.K. Market Analysis

15.8.7.1. Introduction

15.8.7.2. Market Analysis and Forecast by Market Taxonomy

15.8.7.2.1. By Product

15.8.7.2.2. By Indication

15.8.7.2.3. By End User

16. East Asia Market Analysis 2017–2022 and Forecast 2023–2033

16.1. Introduction / Key Findings

16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022

16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. By Product

16.3.3. By Indication

16.3.4. By End User

16.4. Market Attractiveness Analysis By Region

16.4.1. By Country

16.4.2. By Product

16.4.3. By Indication

16.4.4. By End User

16.5. Market trends

16.6. Key Market Participants - Intensity Mapping

16.7. Drivers and Restraints - Impact Analysis

16.8. Country Level Analysis & Forecast

16.8.1. China Market Analysis

16.8.1.1. Introduction

16.8.1.2. Market Analysis and Forecast by Market Taxonomy

16.8.1.2.1. By Product

16.8.1.2.2. By Indication

16.8.1.2.3. By End User

16.8.2. Japan Market Analysis

16.8.2.1. Introduction

16.8.2.2. Market Analysis and Forecast by Market Taxonomy

16.8.2.2.1. By Product

16.8.2.2.2. By Indication

16.8.2.2.3. By End User

16.8.3. South Korea Market Analysis

16.8.3.1. Introduction

16.8.3.2. Market Analysis and Forecast by Market Taxonomy

16.8.3.2.1. By Product

16.8.3.2.2. By Indication

16.8.3.2.3. By End User

17. South Asia Market Analysis 2017–2022 and Forecast 2023–2033

17.1. Introduction / Key Findings

17.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2017–2022

17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033

17.3.1. By Country

17.3.1.1. India

17.3.1.2. Indonesia

17.3.1.3. Thailand

17.3.1.4. Philippines

17.3.1.5. Malaysia

17.3.1.6. Vietnam

17.3.1.7. Rest of South Asia

17.3.2. By Product

17.3.3. By Indication

17.3.4. By End User

17.4. Market Attractiveness Analysis By Region

17.4.1. By Country

17.4.2. By Product

17.4.3. By Indication

17.4.4. By End User

17.5. Market trends

17.6. Key Market Participants - Intensity Mapping

17.7. Drivers and Restraints - Impact Analysis

17.8. Country Level Analysis & Forecast

17.8.1. India Market Analysis

17.8.1.1. Introduction

17.8.1.2. Market Analysis and Forecast by Market Taxonomy

17.8.1.2.1. By Product

17.8.1.2.2. By Indication

17.8.1.2.3. By End User

17.8.2. Indonesia Market Analysis

17.8.2.1. Introduction

17.8.2.2. Market Analysis and Forecast by Market Taxonomy

17.8.2.2.1. By Product

17.8.2.2.2. By Indication

17.8.2.2.3. By End User

17.8.3. Thailand Market Analysis

17.8.3.1. Introduction

17.8.3.2. Market Analysis and Forecast by Market Taxonomy

17.8.3.2.1. By Product

17.8.3.2.2. By Indication

17.8.3.2.3. By End User

17.8.4. Philippines Market Analysis

17.8.4.1. Introduction

17.8.4.2. Market Analysis and Forecast by Market Taxonomy

17.8.4.2.1. By Product

17.8.4.2.2. By Indication

17.8.4.2.3. By End User

17.8.5. Malaysia Market Analysis

17.8.5.1. Introduction

17.8.5.2. Market Analysis and Forecast by Market Taxonomy

17.8.5.2.1. By Product

17.8.5.2.2. By Indication

17.8.5.2.3. By End User

17.8.6. Vietnam Market Analysis

17.8.6.1. Introduction

17.8.6.2. Market Analysis and Forecast by Market Taxonomy

17.8.6.2.1. By Product

17.8.6.2.2. By Indication

17.8.6.2.3. By End User

18. Oceania Market Analysis 2017–2022 and Forecast 2023–2033

18.1. Introduction / Key Findings

18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Market Taxonomy, 2017–2022

18.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033

18.3.1. By Country

18.3.1.1. Australia

18.3.1.2. New Zealand

18.3.2. By Product

18.3.3. By Indication

18.3.4. By End User

18.4. Market Attractiveness Analysis By Region

18.4.1. By Country

18.4.2. By Product

18.4.3. By Indication

18.4.4. By End User

18.5. Market trends

18.6. Key Market Participants - Intensity Mapping

18.7. Drivers and Restraints - Impact Analysis

18.8. Country Level Analysis & Forecast

18.8.1. Australia Market Analysis

18.8.1.1. Introduction

18.8.1.2. Market Analysis and Forecast by Market Taxonomy

18.8.1.2.1. By Product

18.8.1.2.2. By Indication

18.8.1.2.3. By End User

18.8.2. New Zealand Market Analysis

18.8.2.1. Introduction

18.8.2.2. Market Analysis and Forecast by Market Taxonomy

18.8.2.2.1. By Product

18.8.2.2.2. By Indication

18.8.2.2.3. By End User

19. Middle East and Africa Market Analysis 2017–2022 and Forecast 2023–2033

19.1. Introduction / Key Findings

19.2. Historical Market Size (US$ Mn) Volume (Units) Analysis, By Market Taxonomy, 2017–2022

19.3. Current and Future Market Size (US$ Mn) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023–2033

19.3.1. By Country

19.3.1.1. GCC Countries

19.3.1.2. Türkiye

19.3.1.3. Egypt

19.3.1.4. Israel

19.3.1.5. South Africa

19.3.1.6. Northern Africa

19.3.1.7. Rest of Middle East and Africa

19.3.2. By Product

19.3.3. By Indication

19.3.4. By End User

19.4. Market Attractiveness Analysis By Region

19.4.1. By Country

19.4.2. By Product

19.4.3. By Indication

19.4.4. By End User

19.5. Market trends

19.6. Key Market Participants - Intensity Mapping

19.7. Drivers and Restraints - Impact Analysis

19.8. Country Level Analysis & Forecast

19.8.1. GCC Countries Market Analysis

19.8.1.1. Introduction

19.8.1.2. Market Analysis and Forecast by Market Taxonomy

19.8.1.2.1. By Product

19.8.1.2.2. By Indication

19.8.1.2.3. By End User

19.8.2. Türkiye Market Analysis

19.8.2.1. Introduction

19.8.2.2. Market Analysis and Forecast by Market Taxonomy

19.8.2.2.1. By Product

19.8.2.2.2. By Indication

19.8.2.2.3. By End User

19.8.3. Egypt Market Analysis

19.8.3.1. Introduction

19.8.3.2. Market Analysis and Forecast by Market Taxonomy

19.8.3.2.1. By Product

19.8.3.2.2. By Indication

19.8.3.2.3. By End User

19.8.4. Israel Market Analysis

19.8.4.1. Introduction

19.8.4.2. Market Analysis and Forecast by Market Taxonomy

19.8.4.2.1. By Product

19.8.4.2.2. By Indication

19.8.4.2.3. By End User

19.8.5. South Africa Market Analysis

19.8.5.1. Introduction

19.8.5.2. Market Analysis and Forecast by Market Taxonomy

19.8.5.2.1. By Product

19.8.5.2.2. By Indication

19.8.5.2.3. By End User

19.8.6. Northern Africa Market Analysis

19.8.6.1. Introduction

19.8.6.2. Market Analysis and Forecast by Market Taxonomy

19.8.6.2.1. By Product

19.8.6.2.2. By Indication

19.8.6.2.3. By End User

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies

20.2. Market Share Analysis of Top Players (%)

20.3. Market Presence Analysis

20.3.1. Regional Footprint of Players

20.3.2. Product Footprint of Players

20.3.3. Channel Footprint of Players

21. Competition Analysis

21.1. Competition Dashboard

21.2. Key Development Analysis

21.3. Branding and Promotional Strategies, By Key Players

21.4. Competition Deep Dive

21.4.1. Exact Sciences (Genome Health Inc.)

21.4.1.1. Overview

21.4.1.2. Product Portfolio

21.4.1.3. Key Financials

21.4.1.4. Sales Footprint

21.4.1.5. SWOT Analysis

21.4.1.6. Strategy Overview

21.4.1.6.1. Marketing Strategies

21.4.1.6.2. Channel Strategies

21.4.1.6.3. Product Strategies

21.4.2. NanoString Technologies, Inc.

21.4.2.1. Overview

21.4.2.2. Product Portfolio

21.4.2.3. Key Financials

21.4.2.4. Sales Footprint

21.4.2.5. SWOT Analysis

21.4.2.6. Strategy Overview

21.4.2.6.1. Marketing Strategies

21.4.2.6.2. Channel Strategies

21.4.2.6.3. Product Strategies

21.4.3. Foundation Medicine, Inc

21.4.3.1. Overview

21.4.3.2. Product Portfolio

21.4.3.3. Key Financials

21.4.3.4. Sales Footprint

21.4.3.5. SWOT Analysis

21.4.3.6. Strategy Overview

21.4.3.6.1. Marketing Strategies

21.4.3.6.2. Channel Strategies

21.4.3.6.3. Product Strategies

21.4.4. ThermoFisher Scientific

21.4.4.1. Overview

21.4.4.2. Product Portfolio

21.4.4.3. Key Financials

21.4.4.4. Sales Footprint

21.4.4.5. SWOT Analysis

21.4.4.6. Strategy Overview

21.4.4.6.1. Marketing Strategies

21.4.4.6.2. Channel Strategies

21.4.4.6.3. Product Strategies

21.4.5. Illumina, Inc

21.4.5.1. Overview

21.4.5.2. Product Portfolio

21.4.5.3. Key Financials

21.4.5.4. Sales Footprint

21.4.5.5. SWOT Analysis

21.4.5.6. Strategy Overview

21.4.5.6.1. Marketing Strategies

21.4.5.6.2. Channel Strategies

21.4.5.6.3. Product Strategies

21.4.6. Hologic Inc (Biotheranostic)

21.4.6.1. Overview

21.4.6.2. Product Portfolio

21.4.6.3. Key Financials

21.4.6.4. Sales Footprint

21.4.6.5. SWOT Analysis

21.4.6.6. Strategy Overview

21.4.6.6.1. Marketing Strategies

21.4.6.6.2. Channel Strategies

21.4.6.6.3. Product Strategies

21.4.7. Biocartis

21.4.7.1. Overview

21.4.7.2. Product Portfolio

21.4.7.3. Key Financials

21.4.7.4. Sales Footprint

21.4.7.5. SWOT Analysis

21.4.7.6. Strategy Overview

21.4.7.6.1. Marketing Strategies

21.4.7.6.2. Channel Strategies

21.4.7.6.3. Product Strategies

21.4.8. Roche Diagnostics

21.4.8.1. Overview

21.4.8.2. Product Portfolio

21.4.8.3. Key Financials

21.4.8.4. Sales Footprint

21.4.8.5. SWOT Analysis

21.4.8.6. Strategy Overview

21.4.8.6.1. Marketing Strategies

21.4.8.6.2. Channel Strategies

21.4.8.6.3. Product Strategies

21.4.9. Epic Sciences

21.4.9.1. Overview

21.4.9.2. Product Portfolio

21.4.9.3. Key Financials

21.4.9.4. Sales Footprint

21.4.9.5. SWOT Analysis

21.4.9.6. Strategy Overview

21.4.9.6.1. Marketing Strategies

21.4.9.6.2. Channel Strategies

21.4.9.6.3. Product Strategies

21.4.10. Qiagen

21.4.10.1. Overview

21.4.10.2. Product Portfolio

21.4.10.3. Key Financials

21.4.10.4. Sales Footprint

21.4.10.5. SWOT Analysis

21.4.10.6. Strategy Overview

21.4.10.6.1. Marketing Strategies

21.4.10.6.2. Channel Strategies

21.4.10.6.3. Product Strategies

21.4.11. Abbott

21.4.11.1. Overview

21.4.11.2. Product Portfolio

21.4.11.3. Key Financials

21.4.11.4. Sales Footprint

21.4.11.5. SWOT Analysis

21.4.11.6. Strategy Overview

21.4.11.6.1. Marketing Strategies

21.4.11.6.2. Channel Strategies

21.4.11.6.3. Product Strategies

21.4.12. Myriad Genetics, Inc

21.4.12.1. Overview

21.4.12.2. Product Portfolio

21.4.12.3. Key Financials

21.4.12.4. Sales Footprint

21.4.12.5. SWOT Analysis

21.4.12.6. Strategy Overview

21.4.12.6.1. Marketing Strategies

21.4.12.6.2. Channel Strategies

21.4.12.6.3. Product Strategies

21.4.13. Guardant Health

21.4.13.1. Overview

21.4.13.2. Product Portfolio

21.4.13.3. Key Financials

21.4.13.4. Sales Footprint

21.4.13.5. SWOT Analysis

21.4.13.6. Strategy Overview

21.4.13.6.1. Marketing Strategies

21.4.13.6.2. Channel Strategies

21.4.13.6.3. Product Strategies

22. Assumptions and Acronyms Used

23. Research Methodology

ページTOPに戻る

Table of Contents

Summary

Breast Recurrence Score Test Market: Report Scope

The latest publication by Persistence Market Research on the global breast recurrence score test market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 to 2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for breast recurrence score testing products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the breast recurrence score test market. Shareholders in the breast recurrence score test market, industry experts, investors, researchers, and reporters, as well as business enthusiasts, can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as macroeconomic variables affecting the business scenario in the breast recurrence score test market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the breast recurrence score test market offers information divided into four important segments - product, indication, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Attribute Details
Product
Test Kits
Reagents & Consumables
Indication
Stage 1 Breast Cancer
Stage 2 Breast Cancer
Estrogen-receptor Positive Cancer
Lymph-node Negative Cancer
End User
Hospitals
Specialty Cancer Centers
Diagnostic Centers
Cancer Research Institutions
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for breast recurrence score testing products over the coming years?
How will changing trends influence the market?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will influence the market?
How can companies in the breast recurrence score test market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the breast recurrence score test market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the breast recurrence score test market is more accurate and reliable.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Persistence Market Research社はどのような調査会社ですか?

パーシスタンスマーケットリサーチ（Persistence Market Research/PMR）は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

乳房再発スコア検査に関する市場調査：この分野で地域市場をリードする北米

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

Persistence Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?